IP Library › Assignment 069582/0756
Patent Assignment
Reel/Frame 069582/0756

Security Interest

Recorded: 2024-12-13 Pages: 7
Assignor
ESPERION THERAPEUTICS, INC.
Executed: 2024-12-13
Assignee
GLAS AMERICAS LLC
3 SECOND STREET, SUITE 206, JERSEY CITY, NEW JERSEY, 07311
Covered Properties (25)
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/657,105 →
Publication: US 2024/0317665
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/632,996 →
Publication: US 2024/0286987
Salt Forms of Bempedoic Acid and Methods for Using the Same
Application: 17/620,885 →
Publication: US 2023/0141635
Compositions Containing and Therapies Using Bempedoic Acid and Tolvaptan
Application: 18/565,762 →
Publication: US 2024/0366625
Macrocyclic Inhibitors of Atp Citrate Lyase
Application: 18/862,295 →
Publication: US 2025/0289793
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/450,591 →
Publication: US 2024/0182396
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 18/601,088 →
Publication: US 2024/0398746
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 18/949,376 →
Publication: US 2025/0064767
Pharmaceutical Compositions Comprising Granulated Bempedoic Acid
Application: 17/720,625 →
Publication: US 2022/0249380
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application: 17/271,045 →
Publication: US 2021/0322376
Dihydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 7,335,689 →
Application: 10/743,109 →
Publication: US 2004/0214887
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 7,335,799 →
Application: 10/743,470 →
Publication: US 2005/0043278
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 7,812,199 →
Application: 11/680,105 →
Publication: US 2007/0179120
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/150,325 →
Publication: US 2021/0139401
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/577,829 →
Publication: US 2022/0388937
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/742,728 →
Publication: US 2022/0281795
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/867,744 →
Publication: US 2023/0183160
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 18/297,846 →
Publication: US 2023/0250043
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 15/558,084 →
Publication: US 2018/0064671
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 17/136,870 →
Publication: US 2021/0361605
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease
Application: 15/558,519 →
Publication: US 2018/0078518
Methods of Treatment Using Bempedoic Acid
Methods of Treatment Using Bempedoic Acid
Compositions Containing, and Combination Therapies Using Bempedoic Acid and a Glp-1 Receptor Agonist
Macrocyclic Inhibitors of Atp Citrate Lyase
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 7, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015431/0357 →
Assignment of Assignor's Interest Nov 1, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015945/0158 →
Assignment of Assignor's Interest Oct 14, 2014
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033943/0751 →
Merger Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
Security Interest Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
Assignment of Assignor's Interest Oct 25, 2019
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050823/0885 →
Security Interest Apr 26, 2021
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 056044/0988 →
Assignment of Assignor's Interest Jun 13, 2022
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG.
Reel/Frame 060183/0121 →
Assignment of Assignor's Interest Jun 13, 2022
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0088 →
Assignment of Assignor's Interest Jun 13, 2022
From: COPP, RICHARD; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0094 →
Assignment of Assignor's Interest Jun 13, 2022
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 060183/0076 →
Assignment of Assignor's Interest Jun 13, 2022
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0170 →
Assignment of Assignor's Interest Jun 13, 2022
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 060183/0159 →
Assignment of Assignor's Interest Jun 13, 2022
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 060183/0147 →
Assignment of Assignor's Interest Jan 8, 2024
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG
Reel/Frame 066048/0529 →
Assignment of Assignor's Interest Jan 8, 2024
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 066048/0561 →
Assignment of Assignor's Interest Jan 8, 2024
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0570 →
Assignment of Assignor's Interest Jan 8, 2024
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 066048/0576 →
Assignment of Assignor's Interest Jan 8, 2024
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0583 →
Assignment of Assignor's Interest Jan 8, 2024
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0362 →
Assignment of Assignor's Interest Jan 8, 2024
From: COPP, RICHARD; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0513 →
Assignment of Assignor's Interest Jan 8, 2024
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 066048/0540 →
Release of Security Interest Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →
Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement Jul 19, 2024
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 068459/0136 →
Assignment of Assignor's Interest Dec 17, 2024
From: RUBICON RESEARCH PVT. LTD.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 069612/0234 →